Scintigraphic evaluation of small intestinal transit in the streptozotocin induced diabetic rats
dc.authorid | DURMUS ALTUN, GULAY/0000-0002-1822-9386 | |
dc.authorid | vardar, selma arzu/0000-0002-1073-1718 | |
dc.authorwosid | DURMUS ALTUN, GULAY/S-6586-2016 | |
dc.contributor.author | Durmus-Altun, G. | |
dc.contributor.author | Vatansever, U. | |
dc.contributor.author | Arzu, Vardar S. | |
dc.contributor.author | Altaner, S. | |
dc.contributor.author | Dirlik, B. | |
dc.date.accessioned | 2024-06-12T11:14:15Z | |
dc.date.available | 2024-06-12T11:14:15Z | |
dc.date.issued | 2011 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Aim: Small intestine (SI) transit in the streptozotocin (STZ) induced diabetic rats were examined by using 99mTc-mebrofenin scintigraphy. Materials and methods: Wistar albino rats (mean body weight: 220 +/- 12 g) were studied for both control (n=10) and diabetes mellitus (DM) (n=10) groups. Diabetes was induced by a single intraperitoneal injection of streptozotocin (50 mg kg(-1) body weight. SI transit time was assessed by measuring arrival times of 99mTc-mebrofenin from duodenum to caecum. Results: The mean transit time of 99mTc-mebrofenin was 67.8 +/- 11 min in control group. The mean transit time of SI was prolonged in STZ induced diabetic animals with (111.9 +/- 12.5, p=0.01). There was significant correlation between small intestinal transit time and blood glucose level (r: 0.73, p=0.01). Conclusion: We observed that SI transit was prolonged in diabetic animals using 99mTc-mebrofenin, and additionally this technique is a readily available method for the detection of transit abnormalities in animal experiment. Hippokratia 2011; 15 (3): 262-264 | en_US |
dc.identifier.endpage | 264 | en_US |
dc.identifier.issn | 1108-4189 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 22435026 | en_US |
dc.identifier.scopus | 2-s2.0-79959821929 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 262 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/23869 | |
dc.identifier.volume | 15 | en_US |
dc.identifier.wos | WOS:000293229100012 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lithographia | en_US |
dc.relation.ispartof | Hippokratia | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Small Intestine | en_US |
dc.subject | Scintigraphy | en_US |
dc.subject | 99mtc-Mebrofenin | en_US |
dc.subject | Diabetes Mellitus | en_US |
dc.subject | Streptozotocin | en_US |
dc.subject | Concise Communication | en_US |
dc.subject | Small-Bowel | en_US |
dc.subject | Symptoms | en_US |
dc.subject | Mellitus | en_US |
dc.subject | Invitro | en_US |
dc.subject | Injury | en_US |
dc.subject | Hida | en_US |
dc.title | Scintigraphic evaluation of small intestinal transit in the streptozotocin induced diabetic rats | en_US |
dc.type | Article | en_US |